Medicine and Dentistry
Adjuvant Therapy
5%
Alkylating Antineoplastic Agent
5%
Antiinfective Agent
5%
Astrocyte
5%
Blood Brain Barrier
5%
Carcinogenesis
5%
Clinical Significance
5%
Combined Therapy
5%
Cytokine
5%
Drug Resistance
5%
Ganglioglioma
10%
Gene Expression
5%
Gene Overexpression
5%
Glioblastoma
100%
Glioblastoma Cell Line
5%
Intracranial Tumor
5%
Lifespan
5%
microRNA
100%
Neoplasm
5%
Next Generation Sequencing
10%
Promoter Region
10%
Small Untranslated RNA
5%
Survival Rate
5%
Temozolomide
36%
The Cancer Genome Atlas
5%
Therapy Effect
5%
Xenograft
5%
Neuroscience
Adjuvant Therapy
5%
Alkylating Antineoplastic Agent
5%
Astrocyte
5%
Blood Brain Barrier
5%
Carcinogenesis
5%
Cell Line
5%
Drug Resistance
5%
Gene Expression
5%
Gene Overexpression
5%
Glioblastoma Multiforme
100%
In Vivo
5%
Intracranial Tumor
5%
MicroRNA
100%
Promoter Region
10%
Small Untranslated RNA
5%
Temozolomide
36%
Pharmacology, Toxicology and Pharmaceutical Science
Alkylating Agent
5%
Antiinfective Agent
5%
Blood-Brain Barrier
5%
Carcinogenesis
5%
Chemotherapy
5%
Cytokine
5%
Drug Resistance
5%
Glioblastoma
100%
Intracranial Tumor
5%
microRNA
100%
Neoplasm
5%
Small Untranslated RNA
5%
Survival Rate
5%
Temozolomide
36%
Therapeutic Effect
5%